Evidence map›Paper›PMID 33062556›Full record

ArticleThe mental health clinician2020

Development of an innovative adult attention-deficit hyperactivity disorder clinic.

Kelly C Lee, Estelle Kim, Jaye Kim, Benjamin Malcolm, Grace M Kuo, Anne Bird, David Feifel

Abstract read
In one paragraph

Article in The mental health clinician, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Attention Deficit Hyperactivity Disorder: What Are Pharmacists' Roles and Associated Outcomes?International journal of environmental research and public health · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kelly C LeeProfessor of Clinical Pharmacy and Associate Dean for Assessment and Accreditation, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, kellylee@health.ucsd.edu.ORCID https://orcid.org/0000-0002-1674-4210
Estelle KimPharmacist, Walgreens Pharmacy, Bakersfield, California.ORCID https://orcid.org/0000-0003-2934-0888
Jaye KimAmbulatory Care Pharmacist, Riverside University Health System, Moreno Valley, California.ORCID https://orcid.org/0000-0001-7559-7276
Benjamin MalcolmAssistant Professor of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, California.ORCID https://orcid.org/0000-0002-9293-9036
Grace M KuoDean and Professor, Oregon State University, College of Pharmacy, Corvallis Campus; Oregon Health & Science University, Portland Campus, Portland, Oregon.ORCID https://orcid.org/0000-0002-8916-4014
Anne BirdAssociate Clinical Professor & Medical Director - Outpatient Psychiatry Services, Department of Psychiatry, University of California, San Diego School of Medicine and UC San Diego Health, San Diego, California.ORCID https://orcid.org/0000-0002-9066-5019
David FeifelProfessor Emeritus, Department of Psychiatry, University of California, San Diego, California; Director, Kadima Neuropsychiatry Institute, La Jolla, California; Research Health Scientist, Veterans Affairs San Diego Health System, San Diego, California.ORCID https://orcid.org/0000-0002-8185-0220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacist-psychiatrist collaborative clinic models in specialty mental health clinics are limited, and there has been only 1 report of a clinic focused on adult attention-deficit hyperactivity disorder (ADHD). In this article, we describe the successful implementation of a pharmacist-psychiatrist collaborative practice agreement in an adult ADHD clinic at an academic medical center. Adult patients diagnosed with ADHD after a comprehensive assessment, including a full neuropsychological evaluation, were enrolled in the collaborative treatment clinic. The collaboration was a partnership between a psychiatry department and a school of pharmacy at a public university. We report the details of 58 patients and 774 patient encounters at the collaborative pharmacist-psychiatrist practice from March 2015 through June 2018. The visits were billed using traditional medical billing codes for follow-up visits. Pharmacist practice opportunities included psychiatric evaluation, medication management, counseling, and referral to auxiliary services. Challenges to the clinic's success included limited pharmacist time, prescriptive authority, and reimbursement for services from payors. A collaborative practice model targeted at adult ADHD patients may be a unique clinic setting for psychiatric pharmacists.

Indexed as

ADHDcollaborativemedication therapy managementmental healthpsychiatric pharmacist

Identifiers

PMID33062556
PMCPMC7534811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.